Covered recipient · General Payments record
TAYLOR SAFFORD
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,226.88
- Reported across 129 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $290.94 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $107.33 | 6 |
| Novo Nordisk AS | $66.10 | 3 |
| Exeltis, USA Inc. | $56.12 | 3 |
| Exact Sciences Corporation | $30.48 | 2 |
| PFIZER INC. | $17.79 | 1 |
| Organon LLC | $13.12 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $20.87 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139502855 | CMS |
| Astellas Pharma US Inc | $14.45 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139503523 | CMS |
| Astellas Pharma US Inc | $20.93 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139520225 | CMS |
| Astellas Pharma US Inc | $19.68 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139520147 | CMS |
| Astellas Pharma US Inc | $16.56 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139506925 | CMS |
| Astellas Pharma US Inc | $14.84 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139559331 | CMS |
| Exact Sciences Corporation | $14.36 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114868409 | CMS |
| Exact Sciences Corporation | $16.12 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114868423 | CMS |
| Exeltis, USA Inc. | $20.64 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150019043 | CMS |
| Exeltis, USA Inc. | $19.00 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150019045 | CMS |
| Exeltis, USA Inc. | $16.48 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150019047 | CMS |
| Novo Nordisk Inc | $21.38 | 01/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100484291 | CMS |
| Novo Nordisk Inc | $24.32 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100371596 | CMS |
| Novo Nordisk Inc | $20.40 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100223954 | CMS |
| Organon Llc | $6.64 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136193924 | CMS |
| Organon Llc | $6.48 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136193926 | CMS |
| PFIZER INC. | $17.79 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131894124 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.